What to do if semaglutide does not seem to be working Before blaming the peptide, check your reconstitution
Its particularly helpful for individuals who have struggled with their weight for years or have medical conditions, such as diabetes, that require careful management of blood sugar levels
In the meantime, semaglutide is contraindicated in patients with a personal or family history of MTC, as well as in patients with multiple endocrine neoplasia (MEN) type 2 in the US
That status should frame how the evidence is read and communicated
While NAC (N-acetylcysteine) is sometimes used to boost glutathione, people with genetic polymorphisms in cysteine metabolism do not effectively convert it into glutathione
CANADA CA2601784, the compound patent for semaglutide in Canada, was scheduled to expire in March 2026, however, due to Novo Nordisks failure to pay the required maintenance fees, the patent has lapsed and Novo Nordisk's market exclusivity for semaglutide in Canada officially ended on January 4, 2026